DICE Therapeutics
DICE
$47.55
Share price
0.00%
Change (1 day)
176.78%
Change (1 year)
Categories
Operating Margin for DICE Therapeutics (DICE)
Operating Margin at the end of 2021: -4,336.44%
According to DICE Therapeutics's latest financial reports and stock price the company's current Operating Margin is -4,336.44%. At the end of 2021 the company had an Operating Margin of -4,336.44%.
Operating Margin history for DICE Therapeutics from 2019 to 2021
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -4,336.44% | 57.73% |
| 2020 | -2,749.25% | 1129.62% |
| 2019 | -223.58% |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.